Literature DB >> 19197944

A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.

Kent S Boles1, William Vermi, Fabio Facchetti, Anja Fuchs, Timothy J Wilson, Thomas G Diacovo, Marina Cella, Marco Colonna.   

Abstract

Nectins and Nectin-like molecules (Necl) play a critical role in cell polarity within epithelia and in the nervous and reproductive systems. Recently, immune receptors specific for Nectins/Necl have been described. Since the expression and distribution of Nectins/Necl is often subverted during tumorigenesis, it has been suggested that the immune system may use these receptors to recognize and eliminate tumors. Here we describe a novel immunoreceptor, Washington University Cell Adhesion Molecule, which is expressed on human follicular B helper T cells (TFH) and binds a Nectin/Necl family member, the poliovirus receptor (PVR), under both static and flow conditions. Furthermore, we demonstrate that PVR is abundantly expressed by follicular DC (FDC) within the germinal center. These results reveal a novel molecular interaction that mediates adhesion of TFH to FDC and provide the first evidence that immune receptors for Nectins/Necl may be involved the generation of T cell-dependent antibody responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197944      PMCID: PMC3544471          DOI: 10.1002/eji.200839116

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

Review 1.  Biology and pathology of nectins and nectin-like molecules.

Authors:  Toshiaki Sakisaka; Yoshimi Takai
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

Review 2.  PDZ domain proteins of synapses.

Authors:  Eunjoon Kim; Morgan Sheng
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

3.  Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

Authors:  Roberta Castriconi; Alessandra Dondero; Maria Valeria Corrias; Edoardo Lanino; Daniela Pende; Lorenzo Moretta; Cristina Bottino; Alessandro Moretta
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

4.  Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155.

Authors:  Inga Ravens; Sebastian Seth; Reinhold Förster; Günter Bernhardt
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

5.  Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

Authors:  Satoko Tahara-Hanaoka; Kazuko Shibuya; Yuko Onoda; Hua Zhang; Satoshi Yamazaki; Akitomo Miyamoto; Shin-Ichiro Honda; Lewis L Lanier; Akira Shibuya
Journal:  Int Immunol       Date:  2004-04       Impact factor: 4.823

6.  In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines.

Authors:  K M Ansel; L J McHeyzer-Williams; V N Ngo; M G McHeyzer-Williams; J G Cyster
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

7.  DNAM-1 and PVR regulate monocyte migration through endothelial junctions.

Authors:  Nicolas Reymond; Anne-Marie Imbert; Elisabeth Devilard; Stéphanie Fabre; Christian Chabannon; Luc Xerri; Catherine Farnarier; Claudia Cantoni; Cristina Bottino; Alessandro Moretta; Patrice Dubreuil; Marc Lopez
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

8.  Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.

Authors:  Cristina Bottino; Roberta Castriconi; Daniela Pende; Paola Rivera; Marina Nanni; Barbara Carnemolla; Claudia Cantoni; Jessica Grassi; Stefania Marcenaro; Nicolas Reymond; Massimo Vitale; Lorenzo Moretta; Marc Lopez; Alessandro Moretta
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

9.  CD155/PVR plays a key role in cell motility during tumor cell invasion and migration.

Authors:  Kevin E Sloan; Brenda K Eustace; Jean K Stewart; Carol Zehetmeier; Claudia Torella; Marina Simeone; Jennifer E Roy; Christine Unger; David N Louis; Leodevico L Ilag; Daniel G Jay
Journal:  BMC Cancer       Date:  2004-10-07       Impact factor: 4.430

View more
  92 in total

1.  Immune Regulation of sickle Cell Alloimmunization.

Authors:  Karina Yazdanbakhsh; Beth H Shaz; Christopher D Hillyer
Journal:  ISBT Sci Ser       Date:  2016-11-15

Review 2.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

4.  Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer.

Authors:  Xu Lu; Jingwei Liu; Peilin Cui; Tao Liu; Chunmei Piao; Xianghong Xu; Qike Zhang; Man Xiao; Xuesong Liu; Yue Wang; Lin Yang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 5.  A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions.

Authors:  Zhuwei Xu; Boquan Jin
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

6.  Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Authors:  Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis
Journal:  Eur J Immunol       Date:  2011-03-18       Impact factor: 5.532

7.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

8.  T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.

Authors:  Man Li; Pengyan Xia; Ying Du; Shengwu Liu; Guanling Huang; Jun Chen; Honglian Zhang; Ning Hou; Xuan Cheng; Luyu Zhou; Peifeng Li; Xiao Yang; Zusen Fan
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

Review 9.  Tim-3, Lag-3, and TIGIT.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 10.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.